Literature DB >> 12203366

Evidence of increased Id-1 expression and its role in cell proliferation in nasopharyngeal carcinoma cells.

Xianghong Wang1, Kexin Xu, Ming Tat Ling, Y C Wong, Hui Chen Feng, John Nicholls, S W Tsao.   

Abstract

Inhibitor of differentiation or DNA binding (Id-1), a helix-loop-helix transcription factor, has recently been shown to inactivate the retinoblastoma (RB)/p16(INK4a) pathway through down-regulation of p16(INK4a) and increasing phosphorylation of RB in certain cell types. Nasopharyngeal carcinoma (NPC) is a common cancer in Hong Kong, and inactivation of the tumor suppressor RB at transcription level is a rare event in NPC. The objective of this study was to investigate the role of Id-1 in NPC cell proliferation and its expression in NPC samples. An NPC cell line, CNE1, was transfected with a retroviral vector containing a full-length Id-1 cDNA, and six stable transfectant clones were isolated with differential Id-1 expression levels. The effect of ectopic Id-1 expression on serum-independent cell growth, cell-cycle distribution, and expression of proteins associated with RB pathway was studied. The Id-1 expression in five NPC samples was also investigated using immunohistochemistry. Ectopic Id-1 expression in CNE1 cells resulted in an increase in serum-independent cell growth, percentage of cells in S phase, and phosphorylation of RB and cyclin-dependent kinase 2 proteins. In addition, immunohistochemical studies on NPC samples showed that expression of Id-1 was present in NPC cells but absent in normal tissues. This study demonstrates that Id-1 plays an important role in cell proliferation in NPC cells, and our results provide evidence for the first time of the significance of Id-1 expression in NPC cells and suggest a possible role of Id-1 expression in the inactivation of RB and development of NPC. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203366     DOI: 10.1002/mc.10072

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

1.  Physical and functional interaction between the ID1 and p65 for activation of NF-κB.

Authors:  Xiao Peng; Yuna Wang; Swapna Kolli; Junpeng Deng; Li Li; Zhixin Wang; J Usha Raj; Deming Gou
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-16       Impact factor: 4.249

2.  The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

3.  E2A proteins enforce a proliferation checkpoint in developing thymocytes.

Authors:  Isaac Engel; Cornelis Murre
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

4.  Id1 promotes tumor cell migration in nonsmall cell lung cancers.

Authors:  Raka Bhattacharya; Jeanne Kowalski; Allison R Larson; Malcolm Brock; Rhoda M Alani
Journal:  J Oncol       Date:  2010-04-18       Impact factor: 4.375

5.  Id1 overexpression induces tetraploidization and multiple abnormal mitotic phenotypes by modulating aurora A.

Authors:  Cornelia Man; Jack Rosa; Y L Yip; Annie Lai-Man Cheung; Y L Kwong; Stephen J Doxsey; S W Tsao
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

6.  ID2 promotes the expansion and survival of growth-arrested pancreatic beta cells.

Authors:  Hong Hua; Nora Sarvetnick
Journal:  Endocrine       Date:  2008-03-06       Impact factor: 3.633

7.  Id-I stimulates cell proliferation through activation of EGFR in ovarian cancer cells.

Authors:  X Zhang; M-T Ling; H Feng; Y C Wong; S W Tsao; X Wang
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

8.  Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers.

Authors:  M K Maw; J Fujimoto; T Tamaya
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

9.  Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers.

Authors:  K T Lee; Y W Lee; J K Lee; S H Choi; J C Rhee; S S Paik; G Kong
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.